Lightnews — Scholar-powered news

Josep Carreras Leukaemia Research Institute

@carrerasijc.bsky.social

380 followers 120 following 120 posts

🔬 International research institute advancing studies on #leukaemia, #lymphoma, and other #hemopathies. Centre of Exellence Severo Ochoa and @cerca.cat 🌐 Explore our work at https://www.carrerasresearch.org/en

www.carrerasresearch.org

Posts Media Videos Starter Packs

Pinned

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jan 21

Meet the pioneering scientists behind the IJC's research! 🔬✨ We are pleased to present our Starter Pack introducing you to the leading researchers driving advancements in #leukaemia, #lymphoma, and other #hemopathies

Follow us for valuable insights into their pioneering work 👇

go.bsky.app/9rX1Tuw

Reposted by Josep Carreras Leukaemia Research Institute

IDIBAPS @idibaps.bsky.social · 13d

IDIBAPS SEMINAR

Malignant transformation of the immune system and therapeutic solutions

📆6/10 15h
👨‍🔬Ari Melnick, @carrerasijc.bsky.social
📍 Esteve Auditorium, CEK

👉https://f.mtr.cool/earftanszd

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 25

Our common goal: curing childhood leukaemia 🤝

The Josep Carreras Institute, the Josep Carreras Foundation and the Sant Joan de Déu Research Institute launch a joint programme to advance research into paediatric blood cancers 🔬

🔗 Read more: www.carrerasresearch.org/en/news/new-...

1 3

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 23

📢 La unidad de Comunicación del IJC ha sido acreditada como Unidad de Cultura Científica y de la Innovación (UCC+I) por #FECYT.

Un paso clave para seguir acercando la ciencia a la sociedad🔬

🔗 www.carrerasresearch.org/es/noticias/...

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 21

La Dra. Sònia Guil nos habla de su investigación en #SíndromeDeRett y del nuevo fármaco que están desarrollando con el objetivo de revertir sus síntomas.

No te pierdas su entrevista en 'A golpe de bit' en #RNE 📻

Escúchala aquí 👇
www.rtve.es/play/audios/...

QTX153, el fármaco español contra el Síndrome de Rett

El Síndrome de Rett es un trastorno genético neurológico poco frecuente que afecta a la forma en la que se desarrolla el cerebro.

www.rtve.es

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 18

Congratulations, Dr Obiols! 👩‍🔬

Mireia Obiols, researcher at the @jlsardinalab.bsky.social, has successfully defended her #PhD thesis today at the IJC Auditorium.

Proud of your dedication and hard work 💪

1 1

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 17

🚨New research by @jlsardinalab.bsky.social and Gemma Valcarcel published at Science Advances uses a CRISPR technology to control immune cell response to inflammation in the lab.

🔗 Read more: www.carrerasresearch.org/en/news/epig...

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 16

Last #YoungResearchers Seminars before the summer break!

👩‍🔬 Our talented researchers Mar Gusi (Maribel Parra's lab) and Alba Vidal (Anna Bigas' lab) gave excellent presentations yesterday, sharing their work to the rest of the IJC community.

We’ll be back in September with more inspiring seminars✨

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 10

📢 Registration open!

Explore the latest advances in cellular #senescence at the upcoming International Conference of @senescel.org 🧬

📅 06-07 November 2025
📍 Barcelona
More information ⬇️
senescel2025.senescel.org

Co-organised by IJC Group Leader Dr. Verónica Rodilla ‪@vrodillab.bsky.social‬

3 4

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Jul 8

🧬 New research from Pablo Menéndez's lab presents a novel CAR-T cells therapy designed to target 2️⃣ specific markers of T-ALL: the CD1a and CCR9 proteins.

Preclinical results show high efficacy and safety in the lab.

🔗 carrerasresearch.org/en/news/a-ne...

🤝 ISS Aragon, OneChain Immunotherapeutics

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 22

El Dr. @manelesteller.bsky.social , de l’IJC, i el Dr. @macips01.bsky.social reben el premi Jaume Aiguader i Miró de l'Acadèmia de Ciències Mèdiques i de la Salut per “El secret de la vida eterna” 📖

🔗 www.carrerasresearch.org/ca/noticies/...

1 5

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 21

💬🔬 Yesterday we held another inspiring Group Leaders Seminar at the Josep Carreras Institute

Dr Tomàs Navarro and Dr Gaël Roué shared deep insights into the biology and treatment of B-Lymphomas 👏

Sharing science is key to moving forward together 🚀

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 20

This Friday, do not miss Dr Rouault-Pierre's Invited Lecture!

💬 "Metabolic intervention in Myelodysplastic Neoplasm; Endoplasmic Reticulum Stress governs a splicing programme in healthy and malignant cells"

🗓️ 23 May, 12pm CEST
📍IJC Auditorium
Online at 👉 us06web.zoom.us/webinar/regi...

3 6

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 20

🔬🌍 Today, on #ClinicalTrialsDay, we celebrate the power of research to save lives

A hopeful milestone: In a phase I clinical trial, our new CAR-T therapy has shown promising results in patients with a highly resistant lymphoma

📄 Read the full story: www.carrerasresearch.org/en/news/new-...

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 14

Yesteday we officially welcomed Dr Ari Melnick, the new Director of the Josep Carreras Institute.

💬 "I see us as a team united in our purpose to eradicate blood cancers."

He reaffirmed his commitment to scientific progress and collaborative growth in front of #IJC community 🚀

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 14

New study co-led by @manelesteller.bsky.social shows that epigenetic profiling identifies two distinct subtypes of Burkitt lymphoma, allowing early prediction of disease aggressiveness. This could help tailor treatment strategies from diagnosis. 🧬📈

👉 www.carrerasresearch.org/en/news/epig...

Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries

Researchers of the Cancer Epigenetics group at the Josep Carreras Leukaemia Research Institute have discovered that patients with Burkitt lymphoma — a common...

www.carrerasresearch.org

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 5

❗️🔬 New research from @scuartero.bsky.social's lab reveals that CEBPA mutations in #AML increase resistance to inflammation but make cells more vulnerable to protein-folding stress, opening the door to new treatment strategies.

➡️ www.carrerasresearch.org/en/news/a-co...

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 29

New CD30-targeted CAR-T therapy shows 100% overall response and 50% complete remission in Refractory Hodgkin Lymphoma patients

👉 carrerasresearch.org/en/news/new-...

🔬 Led by Dr. Javier Briones, PI at #IJC and @irsantpau.bsky.social @hospitalsantpau.bsky.social

📝 @bloodjournal.bsky.social

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 22

We're pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Institute.

Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases.

Read the full release here: www.carrerasresearch.org/en/news/dr-a...

6 13

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 15

🧬 Genetic susceptibility to cancer explained.

New study by Eduard Porta's lab at @cellpress.bsky.social describes 119 germline variants with significant contribution to cancer onset and progession.

➡️ carrerasresearch.org/en/news/new-...

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 14

Next week, we’re honoured to welcome to IJC Dr. Rainer Storb, a world-leading expert in haematology.

"History of Allogeneic Hematopoietic Cell Transplantation as an Example of Intensive Bench-to-Bedside Research"
🗓️ 24 April - 12pm
📍 IJC Auditorium +Online
🔗 www.carrerasresearch.org/en/events/hi...

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 11

La Dra. @bmjavierre.bsky.social ha sido reconocida con el prestigioso Premio CRIS Excelencia de #CRISContraElCáncerr 🏆

Gracias al programa, su grupo estudiará cómo el ADN 🧬se ve alterado en el tratamiento de la leucemia linfoblástica de células B y cómo esto puede llevar a recaídas.

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 11

Bringing precision to cancer research!
Our collaboration with @missionbio.bsky.social is advancing single-cell DNA sequencing for blood & solid tumors (breast cancer, glioblastoma).

Ready to transform your research?
🔗 Learn more: www.carrerasresearch.org/en/units/sin...

Single cell

The Single Cell Unit (SCU) aims to provide scientific services to the Josep Carreras Institute community as well as external users. It is equipped with cutti...

www.carrerasresearch.org

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 11

We provide full scientific & technical support:
🔬 Project design & experimental planning
🧪 Sample processing & viability testing
📊 Bioinformatics analysis & data interpretation
📑 Customized single-cell protocols

1 1

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 11

Single-cell genomics (Tapestri) goes beyond transcriptomics, offering:
✅ Targeted single-cell DNA-seq (mutation, CNV analysis)
✅ Simultaneous genotype + phenotype profiling
✅ Detection of rare subclones (0.1%), key for studying resistance & relapse

1 1

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · Apr 11

Our Services:
📌 Single-cell RNA-seq & ATAC-seq for gene expression & chromatin analysis
📌 Immune profiling (TCR/BCR sequencing)
📌 Single-cell multiomics: combined RNA & chromatin accessibility (ATAC-seq)
📌 Gene expression in fresh, frozen & FFPE samples

1 1